Clinical trialNCT01603069CompletedPhase 2Interventional

A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease

SponsorAstraZenecaEnrollment51Parkinson's Disease

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a study where AZD3241 or placebo is given to patients with Parkinson's disease in a blinded and randomized assignment. The main objective is to see if safety and tolerability of the drug is acceptable.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Joel Posener, MSD
AZ Neuro
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Birmingham, Alabama, United States
Research Site
Long Beach, California, United States
Research Site
New Haven, Connecticut, United States
Research Site
Atlantis, Florida, United States
Research Site
Boca Raton, Florida, United States
Research Site
Orlando, Florida, United States
Research Site
Sunrise, Florida, United States
Research Site
Tampa, Florida, United States
Research Site
Kansas City, Kansas, United States
Research Site
Bingham Farms, Michigan, United States
Research Site
Omaha, Nebraska, United States
Research Site
Lawrenceville, New Jersey, United States
Research Site
Marlton, New Jersey, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

AZD3241 300 mg BIDAZD3241 600 mg BIDPlacebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Oct 2012
Primary completion: 30 Jun 2013
Completion: 30 Jun 2013
Last update posted: 19 Jul 2013
Registered enrollment: 51
Registry id: NCT01603069

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.